EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin-1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells

被引:141
作者
Kim, I
Ryu, YS
Kwak, HJ
Ahn, SY
Oh, JL
Yancopoulos, GD
Gale, NW
Koh, GY
机构
[1] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Natl Creat Res Initiat Ctr Endothelial Cells, Pohang 790784, South Korea
[2] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
capillary mprphogenesis; p120-RasGAP; ERK1/2; Flk1; Tie2;
D O I
10.1096/fj.01-0805fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interaction between ephrinB2 and EphB4 in endothelial cells at the arterial-venous capillary interface is critical for proper embryonic capillary morphogenesis. However, the intracellular downstream signaling of ephrinB2-EphB in vascular endothelial cells is unknown. This study examined the effect of ephrinB2-induced activation of EphB kinases on vascular endothelial growth factor (VEGF)- and angiopoietin-1 (Ang1)-induced Ras/mitogen-activated protein kinase (MAPK) signaling cascades in human umbilical vein endothelial cells (HUVECs). Reverse transcriptase-polymer chain reaction results showed that HUVECs expressed three kinds of EphB kinases known to bind to ephrinB2: EphB2, EphB3, and EphB4. EphrinB2 not only increased the phosphorylation of EphB2 and EphB4 in a time-dependent manner but also increased recruitment of p120-Ras-GTPase-activating protein (p120-RasGAP) to EphB2 and EphB4. Accordingly, ephrinB2 inhibited VEGF- and Ang1-induced Ras-MAPK activities, whereas ephrinB2 did not alter VEGF-induced Flk phosphorylation or Ang1-induced Tie2 phosphorylation. Furthermore, ephrinB2 suppressed VEGF- and Ang1-induced proliferation and/or migration, which are mediated mainly through Ras/MAPK signaling cascades. From these results, we propose that ephrinB2-EphB, signaling through Ras/MAPK cascade, may be critical for proper morphogenesis of capillary endothelium through the arrest of endothelial cell proliferation and migration at the arterial-venous interface.
引用
收藏
页码:1126 / +
页数:16
相关论文
共 22 条
[1]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[2]   Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization [J].
Chae, JK ;
Kim, I ;
Lim, ST ;
Chung, MJ ;
Kim, WH ;
Kim, HG ;
Ko, JK ;
Koh, GY .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (12) :2573-2578
[3]   Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J].
Davis, S ;
Aldrich, TH ;
Jones, PF ;
Acheson, A ;
Compton, DL ;
Jain, V ;
Ryan, TE ;
Bruno, J ;
Radziejewski, C ;
Maisonpierre, PC ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1161-1169
[4]   Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction [J].
Elowe, S ;
Holland, SJ ;
Kulkarni, S ;
Pawson, T .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (21) :7429-7441
[5]   The ephrins and Eph receptors in neural development [J].
Flanagan, JG ;
Vanderhaeghen, P .
ANNUAL REVIEW OF NEUROSCIENCE, 1998, 21 :309-345
[6]   Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells [J].
Fujikawa, K ;
Scherpenseel, ID ;
Jain, SK ;
Presman, E ;
Varticovski, L .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (02) :663-672
[7]   Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis [J].
Gale, NW ;
Holland, SJ ;
Valenzuela, DM ;
Flenniken, A ;
Pan, L ;
Ryan, TE ;
Henkemeyer, M ;
Strebhardt, K ;
Hirai, H ;
Wilkinson, DG ;
Pawson, T ;
Davis, S ;
Yancopoulos, GD .
NEURON, 1996, 17 (01) :9-19
[8]   Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development [J].
Gale, NW ;
Yancopoulos, GD .
GENES & DEVELOPMENT, 1999, 13 (09) :1055-1066
[9]   Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development [J].
Gerety, SS ;
Wang, HU ;
Chen, ZF ;
Anderson, DJ .
MOLECULAR CELL, 1999, 4 (03) :403-414
[10]  
Holder N, 1999, DEVELOPMENT, V126, P2033